Clinically relevant mouse models of severe spinal muscular atrophy with respiratory distress type 1.

Autor:	Holbrook SE; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609 United States.; The University of Maine, 75 Long Rd., Orono, ME 04469 United States., Hicks AN; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609 United States., Martin PB; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609 United States., Hines TJ; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609 United States., Castro HP; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609 United States., Cox GA; The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609 United States.; The University of Maine, 75 Long Rd., Orono, ME 04469 United States.
Jazyk:	angličtina
Zdroj:	Human molecular genetics [Hum Mol Genet] 2024 Oct 07; Vol. 33 (20), pp. 1800-1814.
DOI:	10.1093/hmg/ddae116
Abstrakt:	Spinal Muscular Atrophy with Respiratory Distress (SMARD1) is a lethal infantile disease, characterized by the loss of motor neurons leading to muscular atrophy, diaphragmatic paralysis, and weakness in the trunk and limbs. Mutations in IGHMBP2, a ubiquitously expressed DNA/RNA helicase, have been shown to cause a wide spectrum of motor neuron disease. Though mutations in IGHMBP2 are mostly associated with SMARD1, milder alleles cause the axonal neuropathy, Charcot-Marie-Tooth disease type 2S (CMT2S), and some null alleles are potentially a risk factor for sudden infant death syndrome (SIDS). Variant heterogeneity studied using an allelic series can be informative in order to create a broad spectrum of models that better exhibit the human variation. We previously identified the nmd2J mouse model of SMARD1, as well as two milder CMT2S mouse models. Here, we used CRISPR-Cas9 genome editing to create three new, more severe Ighmbp2 mouse models of SMARD1, including a null allele, a deletion of C495 (C495del) and a deletion of L362 (L362del). Phenotypic characterization of the IGHMBP2L362del homozygous mutants and IGHMBP2C495del homozygous mutants respectively show a more severe disease presentation than the previous nmd2J model. The IGHMBP2L362del mutants lack a clear denervation in the diaphragm while the IGHMBP2C495del mutants display a neurogenic diaphragmatic phenotype as observed in SMARD1 patients. Characterization of the Ighmbp2-null model indicated neo-natal lethality (median lifespan = 0.5 days). These novel strains expand the spectrum of SMARD1 models to better reflect the clinical continuum observed in the human patients with various IGHMBP2 recessive mutations. (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu